Franklin Biotechnology Discovery A - FBDIX
10204 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
DESCRIPTION:

Date updated:12-11-2007

This fund has a Morningstar rating of 2 stars and is run by Evan McCulloch. McCulloch is a portfolio manager with Franklin Advisers, his employer since 1992. He first joined the company as a management trainee. He holds the Chartered Financial Analyst designation. Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.


Current Returns:

1-Year: -0.23%
3-Year: 5.30%
5-Year: 11.74%

As of 9/30/07

symbol name last price % change open
  • +
  • GILD
    Gilead Sciences
  • $46.09
  • -0.63%
  • $46.31

No Analysis added

People owning GILD also tend to own: ACLALXNBMRNCELGCVHCVSESRX

TheStreet.com Rating: A- What is this?

  • +
  • CELG
    Celgene Corporati
  • $54.77
  • -0.71%
  • $N/A

No Analysis added

People owning CELG also tend to own: GTIACIRADSTXNVARASHBNI

TheStreet.com Rating: C+ What is this?

  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

No Analysis added

People owning DNA also tend to own: AAPLDSCMGOOGXOMDWELXGLW

TheStreet.com Rating: No Rating What is this?

  • +
  • AMGN
    Amgen Inc.
  • $57.46
  • -0.38%
  • $57.47

No Analysis added

People owning AMGN also tend to own: APABACCCOPCVXDOWDRE

TheStreet.com Rating: B What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $54.49
  • -1.23%
  • $55.31

No Analysis added

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

  • +
  • PDLI
    Pdl Biopharma
  • $6.55
  • +0.46%
  • $6.59

No Analysis added

People owning PDLI also tend to own: AMDEXELTASRAFFXBVFAIBBHI

TheStreet.com Rating: C What is this?

  • +
  • VRTX
    Vertex Pharmaceut
  • $37.42
  • -0.51%
  • $N/A

No Analysis added

People owning VRTX also tend to own: EXPEIACIMCDXECAGPALXNATU

TheStreet.com Rating: D- What is this?

  • +
  • MYGN
    Myriad Genetics
  • $21.67
  • 0.00%
  • $N/A

No Analysis added

People owning MYGN also tend to own: ABTACLAETALXNBAXBDXBIIB

TheStreet.com Rating: B- What is this?

previous next

Portfolio not tracked!

  • No Blogs Found

Comments not available

ADD YOUR COMMENTS:

Must-See Charts: Ralcorp, Del Mo...

By Jonas Elmerraji Posted on Feb. 9, 2010 With stocks continuing to underwhelm in yesterday’s trading session, the attention is turning toward trading. After all, tec...

02.09.10 | 12:06 PM
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Feb. 8, 2010 Good Buys For Bad Times: This Barron’s article says with the U.S. economy expected to grow by only 3% in 2010, investors shou...

02.08.10 | 16:28 PM
Cramer's Take on Headline Stocks...

Posted on Feb. 8, 2010 Finance Professor Scott Rothbort will be answering questions on Stockpickr Answers on Monday, Feb. 8. Ask away! Regardless of why a stock is in...

02.08.10 | 14:45 PM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Feb. 8, 2010 Finance Professor Scott Rothbort will be answering questions on Stockpickr Answers on Monday, Feb. 8. Ask away! Investor an...

02.08.10 | 08:39 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Speculation and Rumors
05.22.09 | 01:01 AM From author DaveOfDuke
Pump and Dump Schemes
08.01.09 | 10:52 AM From author CallaLilly
3 Steps to Better Putting
02.10.10 | 00:25 AM From author fanliping
more forums
today 's lists
Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average with the highest yields as of the market close on Feb. 5, 2009. more

Analyst Downgrades

Analyst Downgrades and EPS estimate changes for Feb. 9, 2010. more

Top Open-Market Insider Buys

Below is the list of the top open-market insider buys filed at the SEC on Feb. 8, 2010. more